GRPE elements to help cure HIV via gene therapy

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 16 Apr, 2013

Singapore: A research team from Case Western Reserve University School of Medicine has discovered an approach that could...Read more

Charles River manages 2.9% growth in Q2, 2013

Drug Discovery |  Company results | By BioSpectrum Bureau  | 9 Comment | 01 Aug, 2013

Singapore: Drug development company Charles River Laboratories has marked net sales of $292.9 million in the second quar...Read more

Coherus starts ph3 trial of rheumatoid arthritis biosimilar drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

‎Singapore: US based biosimilar therapeutic developer, Coherus BioSciences, has started its Phase 3 trial of CHS-0...Read more

Study: Novartis' Afinitor hinders kidney tumor

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jan, 2013

Singapore: A phase III study conducted at the Cincinnati Children's Hospital Medical Center, US, has revealed that pati...Read more

Concert Pharma, Celgene enter in $300 mn merger

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 May, 2013

Singapore: Concert Pharmaceuticals entered into a strategic collaboration with Celgene Corporation directed towards deut...Read more

Mother's antibodies may cause autism

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jul, 2013

Singapore: Researchers at University of California have found that prenatal exposure to specific combinations of antibod...Read more

CellSeed withdraws stem cell drug application

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 22 Mar, 2013

Singapore: Europe's CellSeed has withdrawn its application for a centralized marketing authorization for the medicine Or...Read more

Biodiem develops killer for drug-resistant microbes

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Oct, 2012

Singapore: Australian infectious disease therapy and vaccine development company BioDiem is developing an antimicrobial ...Read more

Afatinib proves efficacy in lung cancer treatment

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jun, 2012

Singapore: The LUX-Lung 3 Phase III results showed that lung cancer patients taking the novel compound afatinib, an irre...Read more

Openvas by Daiichi Sankyo launched in Mexico

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

Singapore: Japan-based Daiichi Sankyo has launched antihypertensive franchise olmesartan medoxomil in Mexico under the n...Read more

Osteoporosis is an emerging crisis in APAC: Report

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 1 Comment | 13 Dec, 2013

Singapore: A new report, launched by the International Osteoporosis Foundation (IOF), shows that osteoporosis is a loomi...Read more

Genting to acquire 20% equity stake in TauRx

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 20 Nov, 2012

Singapore: Singapore-based TauRx Pharmaceuticals has received equity investment of $31.5 million from Genting Management...Read more

Nanotherapeutics seeks GE help to step up development

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jan, 2014

Singapore: Biopharmaceutical company Nanotherapeutics has selected GE Healthcare Life Sciences' FlexFactory biomanufactu...Read more

Steroid pioneer gets Heritage Foundation, BIO award

Drug Discovery |  Influencers | By BioSpectrum Bureau  | 3 Comment | 22 Apr, 2013

Singapore: Chemical Heritage Foundation (CHF) and Biotechnology Industry Organization (BIO) have selected Mexican steroi...Read more

Austrianova starts cell bank for cancer therapy

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 21 Mar, 2013

Singapore: Austrianova Singapore has established a research cell bank, the first step towards late-phase clinical trials...Read more

Takeda, Dainippon to market schizophrenia drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 13 Aug, 2013

Singapore: Japanese companies Dainippon Sumitomo Pharma and Takeda Pharmaceutical have obtained approval for marketing a...Read more

Astellas to pay $300 mn for cancer drug conjugates

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Apr, 2013

Singapore: Japan's Astellas Pharma has collaborated with US-based Ambrx for the discovery and development of novel antib...Read more

Jubilant, Janssen expand drug discovery alliance

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 21 Feb, 2014

Singapore: Jubilant Biosys, a subsidiary of Bangalore-based Jubilant Life Sciences, has expanded its drug discovery alli...Read more